Trinity Biotech plc
TRIB
$0.35
$0.012.31%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.07% | 11.69% | -208.23% | 29.19% | -777.14% |
| Total Depreciation and Amortization | 14.88% | 329.41% | -266.52% | 161.14% | -4.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.65% | -33.29% | 349.83% | -41.83% | 533.55% |
| Change in Net Operating Assets | -73.13% | -37.40% | 180.40% | 19.21% | 108.61% |
| Cash from Operations | -144.02% | -55.18% | 1,284.71% | 22.30% | -60.16% |
| Capital Expenditure | 107.01% | 48.61% | 37.20% | 14.06% | -17.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.41% | 37.67% | -302.50% | -294.72% | 40.51% |
| Cash from Investing | 70.62% | 37.92% | -207.18% | -250.11% | 32.41% |
| Total Debt Issued | 249.83% | -69.23% | -- | -- | -- |
| Total Debt Repaid | -29.02% | -31.51% | -19.82% | -18.74% | 5.79% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.05% | 96.01% | 93.87% | -18.01% | -- |
| Cash from Financing | 235.83% | -71.22% | 202.44% | 274.58% | -226.72% |
| Foreign Exchange rate Adjustments | 111.83% | 124.07% | 41.14% | -64.29% | -16.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.17% | -449.02% | 190.54% | 68.91% | -180.12% |